VASCULAR ARCHITECTURAL BARRIERS TO TRANSPORT IN TUMORS

Information

  • Research Project
  • 2012351
  • ApplicationId
    2012351
  • Core Project Number
    R15CA074366
  • Full Project Number
    1R15CA074366-01
  • Serial Number
    74366
  • FOA Number
    PA-96-20
  • Sub Project Id
  • Project Start Date
    7/15/1997 - 27 years ago
  • Project End Date
    6/30/2001 - 23 years ago
  • Program Officer Name
    STONE, HELEN B.
  • Budget Start Date
    7/15/1997 - 27 years ago
  • Budget End Date
    6/30/2001 - 23 years ago
  • Fiscal Year
    1997
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/10/1997 - 27 years ago
Organizations

VASCULAR ARCHITECTURAL BARRIERS TO TRANSPORT IN TUMORS

DESCRIPTION: (Adapted from the applicant's abstract): The goal of this project is to investigate the role of the pathological architecture of tumor vasculature as an obstacle to effective treatment of tumors by chemotherapy and radiotherapy. A computer model of vascular growth patterns, and flow and transport characteristics will be used in conjunction with existing experimental data obtained from human tumors grown in immunodeficient mice to determine the extent to which tumor blood flow behaves like a percolation network. Structural data taken from intravital microscopy of tumors grown in mice will be used as a basis for developing a computer simulation of the vascular growth processes that lead to the seemingly chaotic architecture of tumor vasculature. Predictions of fluid flow behavior, and the spatial and temporal distribution of diffusible substances such as drugs and oxygen will be made. These predictions will then be compared to data obtained from experimental tumors. Preliminary studies show that a percolation model of tumor vasculature is promising as a tool for predicting the size and scale of avascular spaces in tumors and, relative to normal tissues, the greater range of tracer residence times in the blood and the increased spatial heterogeneity of the blood perfusion. The results of this study may help to better explain the existing clinical difficulties in delivering blood-borne treatment to solid tumors, and also to suggest new methods of delivering blood-borne therapies or making modifications to the tumor vasculature in ways that would aid treatment.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R15
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    393
  • Ed Inst. Type
    BIOMED ENGR/COL ENGR/ENGR STA
  • Funding ICs
  • Funding Mechanism
  • Study Section
    RAD
  • Study Section Name
    Radiation Study Section
  • Organization Name
    BUCKNELL UNIVERSITY
  • Organization Department
    ENGINEERING (ALL TYPES)
  • Organization DUNS
  • Organization City
    LEWISBURG
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    17837
  • Organization District
    UNITED STATES